Maria Sjöstrand

👩🏼‍🔬🗽

[Roham Parsa (rohamparsa.bsky.social) @rohamparsa]

I’m very happy to announce that I’ll soon become a Principal Investigator and Group Leader at the Chan Zuckerberg Biohub in New York (@czbiohub)! I’m really looking forward to this new chapter in my life and I’m incredibly excited to get things moving in the lab. #CZBiohubNY🧵1/

[Maria Sjöstrand @MariaSjoestrand]

@CicaCanesso @MSKCancerCenter Amazing 👏👏👏

[Maria Sjöstrand @MariaSjoestrand]

@j_eyquem @KeystoneSymp @Michel_Sadelain That’s an awesome group of people! 😍

[Maria Sjöstrand @MariaSjoestrand]

@j_eyquem @CellCellPress @asokanduke @WilliamNyberg Very cool!! Great job

[Maria Sjöstrand @MariaSjoestrand]

Very exciting future for CAR T cells in autoimmune disease! https://t.co/ByBgLK71NY

[MSK ScienceEducation @MSKEducation]

You can learn more about @MariaSjoestrand's work in papers she co-authored:
https://t.co/LsZPqNe2NJ (@ScienceTM @ScienceMagazine)
https://t.co/dly45OAIrQ (@NatureMedicine @NaturePortfolio)

[Maria Sjöstrand @MariaSjoestrand]

Yours truly! Proud to be a postdoc at MSK.

[MSK ScienceEducation @MSKEducation]

We are one week away from #NPAW2022 and so many phenomenal scientists to meet.

#MSKPostdoc Maria Sjostrand (@MariaSjoestrand) is developing new strategies to target cancer cells with genetically engineered T cells (CAR T cells) in the @Michel_Sadelain lab.
#Sweden 🇸🇪

[MSK ScienceEducation @MSKEducation]

2022 National Postdoc Appreciation Week (#NPAW2022) is coming on 9/19. A week is never enough for us to celebrate our remarkable #MSKPostdocs (@MSKPDA), so we dedicate the entire month of September to them 🥳
Stay tuned to learn about our outstanding scientists @MSKCancerCenter

[Roham Parsa (rohamparsa.bsky.social) @rohamparsa]

⬅️ uninfected vs viral infected ➡️
Polyclonal host CD4 T cells recruited to the small intestine during enteric viral infection. Some of them even takes a break to have a chat with epithelial cells 🤙🏼 #immunity #virus

[Justin Eyquem @j_eyquem]

So excited to share this new study resulting from a collaboration with @MarsonLab @GiedreKrenciute @Ashworth_SF and my lab! Lead by the brilliants @jccarnevale and @ShifrutLab, we show that disrupting RASA2 improves CAR and TCR T cell therapy! https://t.co/YiY5jekooP

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

.@SjoukjeJC, @Michel_Sadelain, and other MSK colleagues report in @natBME the production of potent CD8ab+ CAR T cells devoid of alloreactive potential from T-cell-derived induced pluripotent stem cells. Check it out below 👇"NextGen Living Drugs"